Journal of Commercial Biotechnology — October 2009 issue now available

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 15, Issue 4

Intellectual property and biotechnology innovation: To protect or not protect? (free full-text)
Yali Friedman

The correlation between medical tourism and biotechnology
David G Vequist IV and Erika Valdez

The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview
William Bains

Innovate America: The Technology Innovation Program at NIST
Andrew S Klein and Mrunal S Chapekar

Valuation of complex license contracts
Ralph Villiger and Boris Bogdan

How can pharmaceutical and biotechnology companies maintain a high profitability?
Klaus J Nickisch, Joachim M Greuel and Kerstin M Bode-Greuel

Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry
J Leslie Glick

Building biotechnology teams: Personality does matter
Anne S York, Kim A McCarthy and Todd C Darnold

Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
Rob Hanes and Damon Borich

Legal and Regulatory Update
Bird & Bird and ReedSmith

Book Review: Genomics & society: Legal, ethical and social dimensions
Dr Dominic Clark

Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace
Arlen D Meyers

Book Review: Biotech funding trends: Insights from entrepreneurs and investors
J Leslie Glick